tenk.fyi

Lexeo Therapeutics, Inc.

LXEONasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$98.3M

48.1% YoY

EPS

$-3.09

75.1% YoY

Cash

$35.0M

71.2% YoY

FY 2024 · As of 2024-12-31